Instalab

Reverse T3 Test Blood

Explore whether your body is converting thyroid hormone into its active form or diverting it into an inactive pathway.

Should you take a Reverse T3 test?

This test is most useful if any of these apply to you.

On Thyroid Medication but Still Feeling Off
This test may show whether your T4 is being converted to active hormone or diverted to an inactive form.
Living with Heart Failure
Your free T3 to reverse T3 ratio carries prognostic information your standard labs do not capture.
Dealing with Unexplained Fatigue
This test may reveal a thyroid conversion issue hiding behind normal TSH and free T4 results.
Building a Full Thyroid Picture
Add the missing conversion data to your thyroid panel for a more complete view.

About Reverse T3

Your thyroid makes a hormone called T4, which is essentially a raw material. Before T4 can do anything useful, your cells must convert it into one of two products: active T3, which speeds up metabolism and keeps organs running, or reverse T3 (rT3), an inactive mirror image that does almost nothing. The balance between these two products tells you something your standard thyroid panel cannot: whether your body is actually using the thyroid hormone it produces, or diverting it into a metabolic dead end.

This distinction matters most when you feel terrible but your TSH (thyroid stimulating hormone) and free T4 look normal. Reverse T3 rises during serious illness, prolonged stress, caloric restriction, and even on standard thyroid medication. It is not yet part of any major clinical guideline, and standardized cutpoints do not exist. But for people tracking thyroid function closely, especially those on thyroid hormone replacement who still feel off, rT3 offers an exploratory window into a conversion problem that standard tests simply do not address.

What Reverse T3 Actually Is

Reverse T3 is a small molecule with three iodine atoms attached to an amino acid called tyrosine. It is chemically almost identical to active T3, but the iodine atoms sit in slightly different positions. That small structural difference is enough to make rT3 essentially inactive at the thyroid hormone receptors that control your metabolism. Think of it as a key that fits the lock but cannot turn it.

Your thyroid gland itself produces very little rT3 directly, only about 2.5% of what circulates in your blood. The rest is made in organs like the liver and kidneys by enzymes called deiodinases that strip iodine atoms from T4. When conditions are normal, these enzymes favor making active T3. When the body is under stress, illness, or caloric restriction, the balance shifts toward making more rT3 instead.

Heart Failure and Cardiac Risk

The strongest outcome data for rT3 come from cardiology. In a study of 84 patients with advanced heart failure, a low ratio of free T3 to reverse T3 was one of the strongest predictors of poor short-term survival, outperforming many conventional markers. Patients with the worst ratios had more severe fluid overload and poorer nutritional status.

After a heart attack, the picture is similar. In 331 patients admitted for acute myocardial infarction, those whose rT3 was above the median at admission were at significantly higher risk of dying within one year, independent of other standard risk factors. This pattern suggests that rT3 tracks acute illness severity rather than long-term cardiovascular risk.

If you have heart failure or have survived a cardiac event, an elevated rT3 is a signal that your body's thyroid hormone economy is under strain. It does not mean you have thyroid disease. It means your body is prioritizing energy conservation over metabolic activity, and that pattern tracks with worse cardiac outcomes.

Non-Thyroidal Illness Syndrome

The most common reason for elevated rT3 is a condition called non-thyroidal illness syndrome, sometimes called euthyroid sick syndrome. During serious illness, infection, trauma, surgery, or severe malnutrition, the body deliberately reduces conversion of T4 to active T3 and increases conversion to inactive rT3. The result is low T3, normal or slightly low T4, normal TSH, and elevated rT3.

This pattern has been documented across a wide range of conditions. In 386 hospitalized COVID-19 patients, those admitted to intensive care had significantly lower free T3 to rT3 ratios than those on regular wards, reflecting greater disease severity. In 40 children admitted to a pediatric ICU with shock, non-thyroidal illness syndrome was highly prevalent and correlated with outcomes. Among 1,028 malnourished medical inpatients, those with low T3 at admission had roughly double the risk of dying within 30 days compared to those with normal T3.

The medical consensus treats this pattern as an adaptive response, not a disease requiring thyroid hormone treatment. Your body is essentially throttling back its metabolic rate to conserve energy during a crisis. Major guidelines do not recommend giving thyroid hormone to correct this pattern outside of clinical trials.

Reverse T3 and Thyroid Medication

If you take levothyroxine (synthetic T4) for hypothyroidism, your rT3 level is likely higher than it would be on a regimen containing T3. In a study of 976 patients on various thyroid hormone replacements, about 21% of those on levothyroxine alone had rT3 above the reference range, compared to only 9% of untreated patients and even fewer on T3-containing preparations. The difference was highly statistically significant.

This happens because levothyroxine floods your system with T4, and your deiodinase enzymes convert some of that excess T4 into rT3. Regimens that include T3, either as liothyronine (a synthetic form of active T3) or as part of desiccated thyroid extract (a natural preparation containing both T4 and T3), bypass this conversion step entirely, resulting in lower rT3. Whether this difference in rT3 translates to differences in how patients feel remains debated, but it is a measurable and consistent biological effect.

Other Conditions That Shift Reverse T3

Poorly controlled diabetes can produce a low T3 pattern similar to non-thyroidal illness syndrome, with rT3 rising as a consequence of impaired conversion of T4 to T3 in organs outside the thyroid. Liver disease, particularly cirrhosis, reduces the clearance of rT3 from the blood, causing levels to accumulate even without increased production. Hyperthyroidism also raises rT3, simply because more T4 is being produced and a larger absolute amount gets converted to rT3. Pregnancy and estrogen use raise rT3 through changes in thyroid hormone binding proteins.

Reference Ranges

No major clinical guideline has established standardized reference ranges or risk stratification thresholds for reverse T3. The single modern dataset with an explicit cutpoint comes from a private endocrine practice of 976 symptomatic adults measured by LC-MS/MS (a specialized laboratory technique that is more accurate than older antibody-based methods). That study used an upper limit of normal of 24.1 ng/dL. This is an analytical reference range, not an outcome-validated threshold.

CategoryRange (ng/dL)What It Suggests
Within reference rangeBelow 24.1T4-to-rT3 conversion appears typical; no evidence of excessive diversion away from active T3
Above reference rangeAbove 24.1Increased T4-to-rT3 conversion, possibly from illness, caloric stress, high-dose levothyroxine, or liver dysfunction

These values come from one practice using one assay method. Your lab may use different techniques and report different ranges. Compare your results within the same lab over time for the most meaningful interpretation. No longevity or preventive medicine organization has proposed an "optimal" rT3 target.

When Results Can Be Misleading

Reverse T3 is unusually sensitive to short-term physiological shifts, making single readings easy to misinterpret. In critically ill patients, raising caloric intake from 40% to 100% of needs caused rT3 to drop by about 10% within 24 hours, with effects fading over roughly three days. Any recent illness, surgery, or major dietary change in the days before your blood draw can push rT3 in either direction without reflecting your true baseline.

  • Acute illness or infection: Even a bad cold or flu can shift deiodinase activity toward rT3 production for days to weeks. Wait until you have fully recovered before drawing this test.
  • Caloric restriction or fasting: Skipping meals or dieting aggressively in the days before your draw can raise rT3 as your body conserves energy.
  • Glucocorticoids (dexamethasone, prednisone): These medications increase T4-to-rT3 conversion through direct effects on deiodinase enzymes. In a study of 6 healthy volunteers, dexamethasone stimulated rT3 production substantially. This does not mean the drug is damaging your thyroid. It means your rT3 result may be unreliable while you are taking corticosteroids.
  • Propylthiouracil (PTU): This antithyroid drug inhibits type 1 deiodinase, reducing rT3 clearance and raising levels independently of thyroid status.

Tracking Your Trend

Because rT3 lacks standardized cutpoints and is easily perturbed by illness, medication changes, and caloric status, a single reading tells you very little. The value of this test comes from tracking your number over time under consistent conditions. If you are getting a baseline, draw your blood when you are feeling well, eating normally, and at least two weeks past any acute illness.

Because this is an exploratory marker without consensus thresholds, your own trajectory is more informative than any single published cutpoint. A rising rT3 trend alongside worsening symptoms may point toward a conversion problem worth discussing with an endocrinologist, even if each individual reading falls within a lab's reference range. A stable rT3 in a healthy, well-nourished person provides reassurance that T4 metabolism is proceeding normally.

What Moves This Biomarker

Evidence-backed interventions that affect your Reverse T3 level

Increase
Take amiodarone (antiarrhythmic drug)
Amiodarone contains a large amount of iodine and directly inhibits deiodinase enzymes, causing T4 and rT3 to rise while T3 falls. This is not just a lab artifact. Amiodarone genuinely causes thyroid disease in a significant fraction of users: hypothyroidism in roughly 15 to 25% of patients in iodine-sufficient regions, and hyperthyroidism in roughly 5 to 10% in iodine-deficient areas. If you are on amiodarone, an elevated rT3 could reflect real thyroid dysfunction, not just a medication effect.
MedicationStrong Evidence
Increase
Take levothyroxine (synthetic T4) for hypothyroidism
Levothyroxine raises your rT3 because it provides more T4 for your deiodinase enzymes to convert. In a study of 976 patients, about 21% of those on levothyroxine alone had rT3 above the reference range, compared to 9% of untreated patients. This does not mean the medication is harming you. It means more T4 substrate naturally produces more rT3 as a byproduct. Your thyroid function is being corrected via TSH normalization, even though rT3 rises as a secondary consequence.
MedicationModerate Evidence
Decrease
Switch to a T3-containing thyroid regimen (liothyronine, desiccated thyroid extract, or combination T4/T3)
Adding T3 to your thyroid regimen or switching to T3-only therapy lowers rT3 by bypassing the T4-to-rT3 conversion pathway. In the same 976-patient study, rT3 was lowest in patients on T3-only preparations and intermediate on combination T4/T3 or desiccated thyroid. The difference was highly significant. Whether this lower rT3 translates into feeling better is still debated, but the biological shift is clear and consistent.
MedicationModerate Evidence
Increase
Take selenium (200 mcg/day) plus coenzyme Q10 (200 mg/day)
In a randomized trial of 414 elderly adults with low selenium levels, four years of selenium plus CoQ10 supplementation increased both free T3 and rT3, decreased free T4, and blunted the age-related rise in TSH compared to placebo. This pattern suggests the supplements activated the deiodinase enzymes that convert T4 into both T3 and rT3, increasing overall T4 turnover. The group taking supplements had significantly lower cardiovascular mortality and better quality of life, so the rT3 increase here occurred alongside clear health benefits.
SupplementModest Evidence

Frequently Asked Questions

References

20 studies
  1. Julian Wilson, Thanh Hoang, Martin L Lee, Ma'ayan Epstein, T. C. FriedmanPLOS One2025
  2. Alicja Filipczyk, M. Wujtewicz, Michał Okrągły, Karol P. SteckiewiczJournal of Clinical Medicine2025
  3. N. a. Müller, Nina Kaegi-braun, M. Durmisi, C. Gressies, P. Tribolet, Z. Stanga, B. Mueller, P. SchuetzThe Journal of Clinical Endocrinology and Metabolism2022
  4. J. Schlienger, a. Anceau, G. Chabrier, M. North, Professor F. StephanDiabetologia1982
  5. Ewa Kozłowska, M. Małecka-giełdowska, O. CiepielaJournal of Clinical Medicine2025